Schmeck C - Search Results

1

In silico ADMET traffic lights as a tool for the prioritization of HTS hits.

Lobell M, Hendrix M, Hinzen B, Keldenich J, Meier H, Schmeck C, Schohe-Loop R, Wunberg T, Hillisch A. Lobell M, et al. Among authors: schmeck c. ChemMedChem. 2006 Nov;1(11):1229-36. doi: 10.1002/cmdc.200600168. ChemMedChem. 2006. PMID: 16991174

2

Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits.

Wunberg T, Hendrix M, Hillisch A, Lobell M, Meier H, Schmeck C, Wild H, Hinzen B. Wunberg T, et al. Among authors: schmeck c. Drug Discov Today. 2006 Feb;11(3-4):175-80. doi: 10.1016/S1359-6446(05)03700-1. Drug Discov Today. 2006. PMID: 16533716 Review.

3

Cholesteryl ester transfer protein and its inhibition.

Weber O, Bischoff H, Schmeck C, Böttcher MF. Weber O, et al. Among authors: schmeck c. Cell Mol Life Sci. 2010 Sep;67(18):3139-49. doi: 10.1007/s00018-010-0418-3. Epub 2010 Jun 18. Cell Mol Life Sci. 2010. PMID: 20556633 Free PMC article. Review.

4

Novel heterocyclic thyromimetics. Part 2.

Haning H, Mueller U, Schmidt G, Schmeck C, Voehringer V, Kretschmer A, Bischoff H. Haning H, et al. Among authors: schmeck c. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3992-6. doi: 10.1016/j.bmcl.2007.04.085. Epub 2007 Apr 29. Bioorg Med Chem Lett. 2007. PMID: 17499989

5

Dibenzodioxocinones--a new class of CETP inhibitors.

Brückner D, Hafner FT, Li V, Schmeck C, Telser J, Vakalopoulos A, Wirtz G. Brückner D, et al. Among authors: schmeck c. Bioorg Med Chem Lett. 2005 Aug 1;15(15):3611-4. doi: 10.1016/j.bmcl.2005.05.073. Bioorg Med Chem Lett. 2005. PMID: 15975789

6

Novel heterocyclic thyromimetics.

Haning H, Woltering M, Mueller U, Schmidt G, Schmeck C, Voehringer V, Kretschmer A, Pernerstorfer J. Haning H, et al. Among authors: schmeck c. Bioorg Med Chem Lett. 2005 Apr 1;15(7):1835-40. doi: 10.1016/j.bmcl.2005.02.028. Bioorg Med Chem Lett. 2005. PMID: 15780617

7

Novel tetrahydrochinoline derived CETP inhibitors.

Schmeck C, Gielen-Haertwig H, Vakalopoulos A, Bischoff H, Li V, Wirtz G, Weber O. Schmeck C, et al. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1740-3. doi: 10.1016/j.bmcl.2010.01.071. Epub 2010 Jan 21. Bioorg Med Chem Lett. 2010. PMID: 20137927

8

Chromanol derivatives--a novel class of CETP inhibitors.

Vakalopoulos A, Schmeck C, Thutewohl M, Li V, Bischoff H, Lustig K, Weber O, Paulsen H, Elias H. Vakalopoulos A, et al. Among authors: schmeck c. Bioorg Med Chem Lett. 2011 Jan 1;21(1):488-91. doi: 10.1016/j.bmcl.2010.10.110. Epub 2010 Oct 26. Bioorg Med Chem Lett. 2011. PMID: 21084191

9

Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory.

Beck H, Härter M, Haß B, Schmeck C, Baerfacker L. Beck H, et al. Among authors: schmeck c. Drug Discov Today. 2022 Jun;27(6):1560-1574. doi: 10.1016/j.drudis.2022.02.015. Epub 2022 Feb 21. Drug Discov Today. 2022. PMID: 35202802 Free article. Review.

10

Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/V1a receptor blockade in a preclinical heart failure model.

Mondritzki T, Kolkhof P, Sabbah HN, Gheorghiade M, Fürstner C, Schmeck C, Siedentop H, Schaefer S, Truebel H. Mondritzki T, et al. Among authors: schmeck c. Am J Ther. 2011 Jan;18(1):31-7. doi: 10.1097/MJT.0b013e3181f890ad. Am J Ther. 2011. PMID: 21192248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page